
Opinion|Videos|July 15, 2024
The Role of Treatment Guidelines for HS
Author(s)Vivian Shi, MD, FAAD
Vivian Shi, MD, FAAD, provides an overview of current treatment guidelines for hidradenitis suppurativa and discusses ways to improve upon them.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- What do current hidradenitis suppurativa (HS) treatment guidelines recommend in terms of using biologics in moderate-to-severe disease?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
2
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
3
New Biomarkers, Drug Targets Identified for Colorectal Cancer
4
Real-World Data Show Preventive Nirsevimab Reduces Infant RSV Hospitalizations
5